In a 1st, NIV-Pune isolates, cultures Covids UK variant

NEW DELHI: In a first, Punes National Institute of Virology (NIV) has isolated and cultured the new UK variant of SARS-CoV2, the Indian Council of Medical Research (ICMR) said on Saturday underlining that no other country has so far reported isolation and culture of the latest UK strain. "UK-variant of the virus, with all signature changes, is now successfully isolated and cultured at National Institute of Virology (NIV) from the clinical specimens collected from UK-returnees," ICMR said. Vero-cell lines were used by the scientists of ICMR-NIV to culture the UK-variant of the virus, it added. ....read more

COVID-19: UKs Experience

The UK variant of coronavirus is more transmissible. Join us today for a discussion on the experience of the United Kingdom during the COVID-19 pandemic, on MEDtalks with Dr K K Aggarwal COVID edition, at 7:00 PM.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent2/hall1a.php

CMAAO Coronavirus Facts and Myth Buster: COVID-19 Vaccines (Part 1)

With input from Dr Monica Vasudev1274:COVID-19 Vaccines, [Source: Medscape; Reproduced for educational purposes] ,1.The genetic sequence of SARS-CoV-2 was published on January 11, 2020. ,2.As of December 17, 2020, The New York Times Coronavirus Vaccine Trackerlisted 63 vaccines in human trials, with at least 85 preclinical vaccines under investigation in animals. ....read more

World COVID Meter 2nd January 2021: Acute manageable immunogenic thrombogenic inflammatory contagious viral disease pandemic

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10, 21M August 16, 22M August 19, 23M August 21, 24M August 27, 25M August 30, 26M September 3, 27M September 7, 28M September 10, 29M September 14, 30M September 18, 31M September 21, 32M September 23, 33M September 28, 34M October 1, 35M October 4, 36M October 8, 37M October 11, 38M October 14, 39M October 17, 40M October 19, 41M October 22, 42M October 24, 43M October 26, 44M October 28, 45M October 30, 46M November 2, 47M November 4, 48M November 6, 49M November 7, 50M November 8, 51M November 10, 52M November 12, 53M November 14, 54M November 15, 55M November 17, 56M November 19, 57M November 20, 58M November 22, 59M November 24, 60M November 25, 61M November 27, 62M November 29, 63M December 1, 64M December 2, 65M December 4, 66M December 6, 67M December 7, 68M December 9, 69M December 10, 70M December 12, 71M December 13, 72M December 14, 73M December 15, 74M December 17, 75M December 19, 76M December 20, 77M December 22, 78M December 23, 79M December 26, 80M December 27, 81M December 29, 82M December 30, 83M December 31 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity Coronavirus Cases: 84,352,872,Deaths: 1,834,447,Recovered: 59,621,320 ....read more

Spiritual Prescription - Controlling the Inner Noise

Yoga Sutras of Patanjali define yoga as restraint of the mental states (Chapter 1.2). In the state of total restraint, the mind is devoid of any external object and is in its true self or the consciousness. To control the mind, many Vedic scholars have given their own formulas. Being in touch with one’s own consciousness requires restraining of the mind, intellect and ego on one hand and the triad of rajas, tamas and satwa on the other hand. Every action leads to a memory, which in turn leads to a desire, and with this, a vicious cycle starts. ....read more

Video of The day

Re understanding new covid-19 UK strain

Healthcare News Monitor

Indias 1st Covid-19 vaccines: DCGI approves Serum, Bharat Biotech vaccines for emergency use

livemint.com

NEW DELHI : The Drugs Controller General of India (DCGI) on Sunday approved the Oxford coronavirus vaccine and Bharat Biotechs Covaxin, making it Indias first vaccines against the pandemic. DCGI VG Somani said both the drug firms have submitted data on their trial runs and both have been granted permission for "restricted use".

HMD gets WHO-PQS certification for 0.3 ml Kojak AD Syringe, required for Pfizer’s vaccine

expresspharma.in

The Hindustan Syringes and Medical Devices (HMD) receives the WHO- Performance, Quality and Safety (PQS) certification for its 0.3 ml Kojak AD Syringes, which are mainly required for the Pfizer’s Corona vaccine. The company is also ramping up its production capacity of 0.5 ml Kojak AD (Auto disposal) syringe. Commenting on the WHO-PQS Certification, “Rajiv Nath, Managing Director, Hindustan Syringes and Medical Devices, said, “On December 31, 2020, we got the WHO- PQS certification for our 0.3 ml Kojak AD Syringes. This is required for Pfizer’s vaccine and we started developing in November on request of PATH and UNICEF. The standard AD 0.5 ml syringes could not be used to inject this vaccine. We have already informed the Government of India about its crucial availability without which public healthcare safe injection delivery of Pfizer vaccine is not possible. And next week, we expect to get orders from UNICEF also.”

Drug regulator gives final approval for Covid-19 vaccines of SII, Bharat Biotech

hindustantimes.com

The Drugs Controller General of India (DCGI) on Sunday formally announced the final approval for Oxford-AstraZeneca and Bharat Biotech vaccines against the coronavirus disease (Covid-19) vaccines for emergency use. “CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines,” DCGI VG Somani said in a press conference. The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use. Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Oxford COVID-19 vaccine, Bharat Biotech’s Covaxin get DCGI approval for emergency use

indianexpress.com

The Drug Controller General of India (DCGI) on Sunday approved the emergency use of both Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin for immunisation against Covid-19 in India. Addressing the media, the DCGI said, “After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of Serum Institute and Bharat Biotech are being approved for restricted use in emergency situation and permission is being granted to Cadila Healthcare for the conduct of Phase III clinical trial.” On January 1, Covishield was recommended for emergency use whereas Covaxin was recommended for restricted use on January 2.